日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer

基底样乳腺癌分化抑制剂 4 (ID4) 的蛋白质组学分析

Laura A Baker, Holly Holliday, Daniel Roden, Christoph Krisp, Sunny Z Wu, Simon Junankar, Aurelien A Serandour, Hisham Mohammed, Radhika Nair, Geetha Sankaranarayanan, Andrew M K Law, Andrea McFarland, Peter T Simpson, Sunil Lakhani, Eoin Dodson, Christina Selinger, Lyndal Anderson, Goli Samimi, Nev

INC280, an orally available small molecule inhibitor of c-MET, reduces migration and adhesion in ovarian cancer cell models

INC280 是一种口服的 c-MET 小分子抑制剂,可降低卵巢癌细胞模型中的迁移和粘附

Kim Moran-Jones, Laura M Brown, Goli Samimi

Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer

结缔组织生长因子作为高级别浆液性卵巢癌的新治疗靶点

Kim Moran-Jones, Brian S Gloss, Rajmohan Murali, David K Chang, Emily K Colvin, Marc D Jones, Samuel Yuen, Viive M Howell, Laura M Brown, Carol W Wong, Suzanne M Spong, Christopher J Scarlett, Neville F Hacker, Sue Ghosh, Samuel C Mok, Michael J Birrer, Goli Samimi

A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2

预测晚期卵巢癌结果的基因特征确定了生存因素:微纤维相关糖蛋白 2

Samuel C Mok, Tomas Bonome, Vinod Vathipadiekal, Aaron Bell, Michael E Johnson, Kwong-kwok Wong, Dong-Choon Park, Ke Hao, Daniel K P Yip, Howard Donninger, Laurent Ozbun, Goli Samimi, John Brady, Mike Randonovich, Cindy A Pise-Masison, J Carl Barrett, Wing H Wong, William R Welch, Ross S Berkowitz,